Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors

被引：16
|
作者：
Gravani, A. [1 ]
Gaitanis, G. [1 ]
Tsironi, T. [1 ]
Tigas, S. [2 ]
Bassukas, I. D. [1 ]
机构：
[1] Univ Ioannina, Sch Hlth Sci, Dept Skin & Venereal Dis, Fac Med, Ioannina, Greece
[2] Univ Ioannina, Sch Hlth Sci, Dept Endocrinol, Fac Med, Ioannina, Greece
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 12期
关键词：
D O I：
10.1111/jdv.14957
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
下载
收藏
页码：E438 / E439
页数：2
相关论文
共 50 条
  • [31] Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors-One due to Linagliptin
    Ildefonso Mendonca, Francisco Manuel
    Jose Martin-Gutierrez, Francisco
    Jose Rios-Martin, Juan
    Camacho-Martinez, Francisco
    DERMATOLOGY, 2016, 232 (02) : 249 - 253
  • [32] Dipeptidyl peptidase 4 inhibitors linked bullous pemphigoid in patients with type 2 diabetes mellitus: A series of 13 cases
    Jha, Alka
    Misra, Anoop
    Gupta, Ritesh
    Ghosh, Amerta
    Tyagi, Kanika
    Dutta, Koel
    Arora, Bhavya
    Durani, Suhail
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (03) : 213 - 216
  • [33] The Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus: Cardiovascular Safety
    Green, Jennifer B.
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 54 - 61
  • [34] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    不详
    JOURNAL OF DIABETES, 2009, 1 (01) : 6 - 7
  • [35] Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
    Muramatsu, Ken
    Zheng, Miao
    Yoshimoto, Norihiro
    Ito, Takamasa
    Ujiie, Inkin
    Iwata, Hiroaki
    Shimizu, Hiroshi
    Ujiie, Hideyuki
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 100 (01) : 23 - 30
  • [36] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Lerch, C. L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [37] Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes
    Douros, Antonios
    Rouette, Julie
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (08) : 1496 - 1503
  • [38] Dipeptidyl peptidase-4 inhibitors/metforminBullous pemphigoid: 5 case reports
    Reactions Weekly, 2018, 1699 (1) : 101 - 101
  • [39] Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
    Ahren, Bo
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (04) : 593 - 607
  • [40] The association between clinical and laboratory findings of bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in the elderly: a retrospective study
    Mokos, Zrinka Bukvic
    Petkovic, Mikela
    Balic, Anamaria
    Marinovic, Branka
    CROATIAN MEDICAL JOURNAL, 2020, 61 (02) : 93 - 99
12345